文章管理
Fi Asia Thailand 2025 Recap|Glac Highlights Postbiotics, Multi-Strain Probiotics, and CDMO Expertise
Glac Biotech was honored to meet industry partners, clients, and experts from around the world, exchanging insights on the latest trends and applications in probiotics and postbiotics.
✨ Event Highlights
1. Comprehensive Capabilities Across Probiotics × Postbiotics × CDMO Development
At the exhibition, Glac Biotech presented its fully integrated development capabilities—from strain development, postbiotic manufacturing and raw material supply, to CDMO / ODM / OEM product support.
We are committed to providing end-to-end solutions, enabling brand partners to turn concepts into market-ready products with scientific validation and robust manufacturing processes.
2. Totipro® PE0401 (Postbiotics) as a Key Highlight
What is Totipro®?
Totipro® is Glac’s proprietary postbiotic ingredient line developed through an in-house fermentation and stabilization process.
It contains bioactive metabolites produced by specific probiotic strains, offering enhanced stability and formulation versatility.
Advantages of Postbiotics:
With high stability, heat tolerance, and no cold-chain requirements, Totipro® PE0401 is suitable for a wide range of product formats, including:
Cookies
Beverages
Chocolate
Capsules, tablets, and powder dietary supplements
Its cross-format compatibility makes postbiotics one of the fastest-growing ingredient categories in the global functional nutrition market.
3. International Recognition for PE0401
Totipro® PE0401 was awarded the 2023 NutraIngredients-Asia Awards – Ingredient of the Year: Microbiome Modulation,
one of the most respected distinctions in the international nutraceutical and microbiome industry.
PE0401 is among the few postbiotic ingredients in Asia to receive this honor, reflecting its leadership in scientific substantiation, formulation flexibility, and ingredient innovation.
🤝 Connecting With the Industry
Throughout the exhibition, Glac’s booth attracted continuous interest from visitors.
We engaged in in-depth discussions on technology, formulation design, and product development opportunities.
We extend our sincere appreciation to everyone who visited us and explored our raw materials and R&D capabilities.
Your support drives Glac Biotech’s commitment to advancing microbiome innovation.
We look forward to meeting you again at upcoming industry events.
